GENinCode Plc (LON:GENI – Get Free Report)’s stock price traded down 3.6% on Friday . The company traded as low as GBX 3.86 ($0.05) and last traded at GBX 4 ($0.05). 82,396 shares were traded during trading, a decline of 59% from the average session volume of 203,110 shares. The stock had previously closed at GBX 4.15 ($0.05).
GENinCode Price Performance
The business has a 50-day moving average price of GBX 5.15 and a two-hundred day moving average price of GBX 6.38. The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.27. The company has a market capitalization of £7.08 million, a price-to-earnings ratio of -80.00 and a beta of 0.66.
GENinCode Company Profile
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Further Reading
- Five stocks we like better than GENinCode
- How to Choose Top Rated Stocks
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- ETF Screener: Uses and Step-by-Step Guide
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- The 3 Best Blue-Chip Stocks to Buy Now
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
